Skip to main content
Caplight Logo









Hua Medicine

Hua Medicine

Public
Shanghai, ShanghaiBiotechwww.huamedicine.com

Hua Medicine is now publicly traded

The data on this page reflects Hua Medicine's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Sep 14, 2018

Last Round

Series D

Mar 27, 2018

Total Funding Raised

$374.74M

Company Overview

Hua Medicine operates in Biotech and is based in Shanghai, Shanghai. Its recorded funding history includes a Series D round in March 2018.

Hua Medicine (HKG: 02552) is a biopharmaceutical company focused on the development and commercialization of Dorzagliatin (HMS5552), a first-in-class oral medication for the treatment of Type 2 diabetes, primarily operating in the PRC.

Sector

Biotech

AI Layer

Non-AI

Hua Medicine Comparables

Compare Hua Medicine with similar companies based on industry and business-model similarity.

No comparables are published for Hua Medicine. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Hua Medicine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOSep 14, 2018
Series DMar 27, 2018
Series CApr 22, 2016
Series BJan 8, 2015
Series AMay 16, 2014
Series A
Sep 20, 2011
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Hua Medicine Investors

Notable investors and investment history

Hua Medicine investors
InvestorRounds
Guotai Junan Securities (Hong Kong) LimitedIPO
Harvest Global InvestmentsSeries C
Frontline BioVenturesSeries C, Series B
Harvest Global InvestmentsSeries C, Series D
Blue Pool CapitalSeries D
Ally Bridge GroupSeries D, Series C, Series B
TF CapitalSeries C, Series B
Book a demo to see all 22 investors

For institutional investors. Book with your work email.

Hua Medicine Filings

Explore SEC and related filing metadata, where available.

Hua Medicine filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2011
Last FundingMar 27, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?